Relationship between periodontitis and diabetes: Lessons from rodent studies

Journal of Periodontology

Volumn 78, Issue 7, 2007, Pages 1264-1275

  Pontes Andersen, Carla C ^a   Flyvbjerg, Allan ^b   Buschard, Karsten ^c   Holmstrup, Palle ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c Rigshospitalet   (Denmark)

Author keywords

Animal; Diabetes; Models; Periodontal disease; Periodontitis

Indexed keywords

ANIMAL; DISEASE MODEL; HOSPITALIZATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; MOUSE MUTANT; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; PERIODONTITIS; PERIODONTIUM; RAT; RAT STRAIN; REVIEW;

ANIMALS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, KNOCKOUT; PERIODONTITIS; PERIODONTIUM; RATS; RATS, INBRED STRAINS; SEVERITY OF ILLNESS INDEX;

EID: 34547472621     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2007.060491     Document Type: Review

References (151)

1. Chen D, Wang MW. Development and application of rodent models for type 2 diabetes. Diabetes Obes Metab 2005;7:307-317.
2. Diamond J. The double puzzle of diabetes. Nature 2003;423:599-602.
3. Marshall SM, Flyvbjerg A. Prevention and early detection of vascular complications of diabetes. BMJ 2006;333:475-480.
4. Barr RG, Nathan DM, Meigs JB, Singer DE. Tests of glycemia for the diagnosis of type 2 diabetes mellitus. Ann Intern Med 2002;137:263-272.
5. Löe H. Periodontal disease. The sixth complication of diabetes mellitus. Diabetes Care 1993;16:329-334.
6. Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet 2005;366:1809-1820.
7. Emrich LJ, Shlossman M, Genco RJ. Periodontal disease in non-insulin-dependent diabetes mellitus. J Periodontol 1991;62:123-131.
8. Grossi SG, Zambon JJ, Ho AW, et al. Assessment of risk for periodontal disease. I. Risk indicators for attachment loss. J Periodontol 1994;65:260-267.
9. Hugoson A, Thorstensson H, Falk H, Kuylenstierna J. Periodontal conditions in insulin-dependent diabetics. J Clin Periodontol 1989;16:215-223.
10. Nelson RG, Shlossman M, Budding LM, et al. Periodontal disease and NIDDM in Pima Indians. Diabetes Care 1990;13:836-840.
11. Oliver RC, Tervonen T. Periodontitis and tooth loss: Comparing diabetics with the general population. J Am Dent Assoc 1993;124:71-76.
12. Papapanou PN. Periodontal diseases: Epidemiology. Ann Periodontol 1996;1:1-36.
13. American Academy of Periodontology. Diabetes and periodontal diseases (position paper). J Periodontol 1996;67:166-176.
14. Beck J, Garcia R, Heiss G, Vokonas PS, Offenbacher S. Periodontal disease and cardiovascular disease. J Periodontol 1996;67(Suppl.):1123-1137.
15. Grossi SG. Treatment of periodontal disease and control of diabetes: An assessment of the evidence and need for future research. Ann Periodontol 2001; 6:138-145.
16. Page RC. The pathobiology of periodontal diseases may affect systemic diseases: Inversion of a paradigm. Ann Periodontol 1998;3:108-120.
17. Li X, Kolltveit KM, Tronstad L, Olsen I. Systemic diseases caused by oral infection. Clin Microbiol Rev 2000;13:547-558.
18. Kaplan JR, Wagner JD. Type 2 diabetes - An introduction to the development and use of animal models. ILAR J 2006;47:181-185.
19. Lalla E, Lamster IB, Stern DM, Schmidt AM. Receptor for advanced glycation end products, inflammation, and accelerated periodontal disease in diabetes: Mechanisms and insights into therapeutic modalities. Ann Periodontol 2001;6:113-118.
20. Lamster IB, Lalla E. Periodontal disease and diabetes mellitus: Discussion, conclusions, and recommendations. Ann Periodontol 2001;6:146-149.
21. Mealey BL, Oates TW. Diabetes mellitus and periodontal diseases. J Periodontol 2006;77:1289-1303.
22. Pucher J, Stewart J. Periodontol disease and diabetes mellitus. Curr Diab Rep 2004;4:46-50.
23. Iacopino AM. Periodontitis and diabetes interrelationships: Role of inflammation. Ann Periodontol 2001; 6:125-137.
24. Madden TE, Caton JG. Animal models for periodontal disease. Methods Enzymol 1994;235:106-119.
25. Dennis MB Jr. Welfare issues of genetically modified animals. Available at: http://dels.nas.edu/ilar_n/ilarjournal/43_2/Welfare.shtml. Accessed January 1, 2007.
26. Hageman I, Buschard K. Diabetic animal models. In: Svendsen P, Jau J, eds. Handbook of Laboratorial Animal Science, vol. II. Boca Raton, FL: CRC Press; 1994:103-123.
27. Bolzan AD, Bianchi MS. Genotoxicity of streptozotocin. Mutat Res 2002;512:121-134.
28. Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 2001;50:537-546.
29. Brondum E, Nilsson H, Aalkjaer C. Functional abnormalities in isolated arteries from Goto-Kakizaki and streptozotocin-treated diabetic rat models. Horm Metab Res 2005;37(Suppl. 1):56-60.
30. Marliss EB, Nakhooda AF, Poussier P. Clinical forms and natural history of the diabetic syndrome and insulin and glucagon secretion in the BB rat. Metabolism 1983;32:11-17.
31. Yang Y, Santamaria P. Lessons on autoimmune diabetes from animal models. Clin Sci (Lond) 2006; 110:627-639.
32. Sieher FE, Traystman RJ. Ethical issues involved in the development of animal models for type I diabetes. Available at: http://dels.nas.edu/ ilar_n/ilarjournal/35_1/35_1Ethical.shtml. Accessed May 10, 2006.
33. Pathophysiology of the endocrine system. Available at: http:// www.vivo.colostate.edu/hbooks/pathphys/endocrine/bodyweight/leptin.html. Accessed October 3, 2006.
34. Janssen U, Phillips AO, Floege J. Rodent models of nephropathy associated with type II diabetes. J Nephrol 1999;12:159-172.
35. Iida M, Murakami T, Ishida K, Mizuno A, Kuwajima M, Shima K. Substitution at codon 269 (glutamine → proline) of the leptin receptor (OB-R) cDNA is the only mutation found in the Zucker fatty (fa/fa) rat. Biochem Biophys Res Commun 1996;224:597-604.
36. Garnett KE, Chapman P, Chambers JA, Waddell ID, Boam DS. Differential gene expression between Zucker Fatty rats and Zucker Diabetic Fatty rats: A potential role for the immediate-early gene Egr-1 in regulation of beta cell proliferation. J Mol Endocrinol 2005;35:13-25.
37. Östenson CG. The Goto-Kakizaki rat. In: Shafrir E, Sima AAF, eds. Animal Models in Diabetes: A Primer. Amsterdam: Harwood Academic Publisher; 2001: 191-303.
38. Ingalls AM, Dickie MM, Snell GD. Obese, a new mutation in the house mouse. J Hered 1950;41:317-318.
39. Sharma K, McCue P, Dunn SR. Diabetic kidney disease in the db/db mouse. Am J Physiol Renal Physiol 2003;284:F1138-F1144.
40. Crawford JM, Taubman MA, Smith DJ. The natural history of periodontal bone loss in germfree and gnotobiotic rats infected with periodontopathic microorganisms. J Periodontal Res 1978; 13:316-325.
41. Evans RT, Klausen B, Sojar HT, et al. Immunization with Porphyromonas (Bacteroides) gingivalis fimbriae protects against periodontal destruction. Infect Immun 1992;60:2926-2935.
42. Genco CA, Van DT, Amar S. Animal models for Porphyromonas gingivalis-mediated periodontal disease. Trends Microbiol 1998;6:444-449.
43. Bentzen BH, Grauballe MC, Bjornsson M, Stoltze K, Hjørting-Hansen E, Holmstrup P. A comparison of two models of experimental periodontitis in rats. Scand J Lab Anim Sci 2005;32:73-80.
44. Liu R, Bal HS, Desta T, et al. Diabetes enhances periodontal bone loss through enhanced resorption and diminished bone formation. J Dent Res 2006;85: 510-514.
45. Rovin S, Costich ER, Gordon HA. The influence of bacteria and irritation in the initiation of periodontal disease in germfree and conventional rats. J Periodontal Res 1966;1:193-204.
46. Samejima Y, Ebisu S, Okada H. Effect of infection with Eikenella corrodens on the progression of ligature-induced periodontitis in rats. J Periodontal Res 1990;25:308-315.
47. Bjornsson M J, Velschow S, Stoltze K, Havemose-Poulsen A, Schou S, Holmstrup P. The influence of diet consistence, drinking water and bedding on periodontal disease in Sprague-Dawley rats. J Periodontal Res 2003;38:543-550.
48. Page RC, Schroeder HE. Periodontitis in Man and Other Animals. New York: Karger; 1982:58-106.
49. Chang KM, Ramamurthy NS, McNamara TF, et al. Tetracyclines inhibit Porphyromonas gingivalis-induced alveolar bone loss in rats by a non-antimicrobial mechanism. J Periodontal Res 1994;29:242-249.
50. Fiehn NE, Klausen B, Evans RT. Periodontal bone loss in Porphyromonas gingivalis-infected specific pathogen-free rats after preinoculation with endogenous Streptococcus sanguis. J Periodontal Res 1992; 27:609-614.
51. Bissada NF, Schaffer EM, Lazarow A. Effect of alloxan diabetes and local irritating factors on the periodontal structures of the rat. Periodontics 1966;4:233-240.
52. Chang K, Rani AS, Chang K, Kumar S. Plasminogen activator activity is decreased in rat gingiva during diabetes. J Periodontol 1996;67:743-747.
53. Chang KM, Ramamurthy NS, McNamara TF, Genco RJ, Golub LM. Infection with a Gram-negative organism stimulates gingival collagenase production in non-diabetic and diabetic germfree rats. J Periodontal Res 1988;23:239-244.
54. Chang KM, Ryan ME, Golub LM, Ramamurthy NS, McNamara TF. Local and systemic factors in periodontal disease increase matrix-degrading enzyme activities in rat gingiva: Effect of micocycline therapy. Res Commun Mol Pathol Pharmacol 1996;91:303-318.
55. Doxey DL, Nares S, Park B, Trieu C, Cutler CW, Iacopino AM. Diabetes-induced impairment of macrophage cytokine release in a rat model: Potential role of serum lipids. Life Sci 1998;63:1127-1136.
56. Glickman I, Smulow JB, Moreau J. Effect of alloxan diabetes upon the periodontal response to excessive occlusal forces. J Periodontol 1966;37:146-155.
57. Golub LM, Garant PR, Ramamurthy NS. Inflammatory changes in gingival collagen in the alloxan-diabetic rat. J Periodontal Res 1977;12:402-418.
58. Golub LM, Schneir M, Ramamurthy NS. Enhanced collagenase activity in diabetic rat gingiva: In vitro and in vivo evidence. J Dent Res 1978;57:520-525.
59. Gul N, Ozsoy N. The ultrastructure of the capillaries in the gingiva of alloxan-induced diabetic rats. Cell Biochem Funct 2003;21:311-315.
60. Hayashi A, Shinohara M, Ohura K. Effect of insulin on naturally occurring gingivitis rats with diabetes. J Osaka Dent Univ 1999;33:1-7.
61. Holzhausen M, Garcia DF, Pepato MT, Marcantonio E Jr. The influence of short-term diabetes mellitus and insulin therapy on alveolar bone loss in rats. J Periodontal Res 2004;39:188-193.
62. Inoue H, Shinohara M, Ohura K. The effect of leukocyte function of streptozotocin-induced diabetes in naturally occurring gingivitis rat. J Osaka Dent Univ 1997;31:47-54.
63. Johnson RB. Effects of experimental diabetes mellitus on alveolar bone loss in periodontal disease-susceptible mice. J Periodontal Res 1985;20:307-316.
64. Johnson RB. Morphological characteristics of the depository surface of alveolar bone of diabetic mice. J Periodontal Res 1992;27:40-47.
65. Lalla E, Lamster IB, Schmidt AM. Enhanced interaction of advanced glycation end products with their cellular receptor RAGE: Implications for the pathogenesis of accelerated periodontal disease in diabetes. Ann Periodontol 1998;3:13-19.
66. Lalla E, Lamster IB, Drury S, Fu C, Schmidt AM. Hyperglycemia, glycoxidation and receptor for advanced glycation endproducts: Potential mechanisms underlying diabetic complications, including diabetes-associated periodontitis. Periodontol 2000 2000;23: 50-62.
67. Lalla E, Lamster IB, Felt M, et al. Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice. J Clin Invest 2000;105:1117-1124.
68. McNamara TF, Ramamurthy NS, Mulvihill JE, Golub LM. The development of an altered gingival crevicular microflora in the alloxan-diabetic rat. Arch Oral Biol 1982;27:217-223.
69. Ozsoy N, Bostanci H, Ayvali C. The investigation of the ultrastructural neutrophil changes in alloxan-induced diabetes in rats: Response to a chemotactic challenge. Cell Biochem Funct 2004;22:81-87.
70. Ramamurthy NS, Zebrowski EJ, Golub LM. The effect of alloxan diabetes on gingival collagen metabolism in rats. Arch Oral Biol 1972;17:1551-1560.
71. Ramamurthy NS, Zebrowski EJ, Golub LM. Collagenolytic activity of gingivae from alloxan-diabetic rats. Diabetes 1973;22:272-274.
72. Ramamurthy NS, Siegel M, Iacono VJ, Golub LM. Leucocyte response in the gingival crevice of the diabetic rat. J Periodontal Res 1979;14:289-296.
73. Ramamurthy NS, Greenwald RA, Schneir M, Golub LM. The effect of alloxan diabetes on prolyl and lysyl hydroxylase activity in uninflamed and inflamed rat gingiva. Arch Oral Biol 1985;30:679-683.
74. Reuterving CO, Hagg E, Gustafson GT. Root surface caries and periodontal disease in long-term alloxan diabetic rats. J Dent Res 1986;65:689-694.
75. Reuterving CO. Pilocarpine-stimulated salivary flow rate and salivary glucose concentration in alloxan diabetic rats. Influence of severity and duration of diabetes. Acta Physiol Scand 1986;126:511-515.
76. Ryan ME, Ramamurthy NS, Sorsa T, Golub LM. MMP-mediated events in diabetes. Ann N Y Acad Sci 1999;878:311-334.
77. Sasaki T, Ramamurthy NS, Yu Z, Golub LM. Tetracycline administration increases protein (presumably procollagen) synthesis and secretion in periodontal ligament fibroblasts of streptozotocin-induced diabetic rats. J Periodontal Res 1992;27:631-639.
78. Schmidt AM, Weidman E, Lalla E, et al. Advanced glycation endproducts (AGEs) induce oxidant stress in the gingiva: A potential mechanism underlying accelerated periodontal disease associated with diabetes. J Periodontal Res 1996;31:508-515.
79. Schneir M, Imberman M, Ramamurthy N, Golub L. Streptozotocin-induced diabetes and the rat periodontium: Decreased relative collagen production. Coll Relat Res 1988;8:221-232.
80. Schneir ML, Ramamurthy NS, Golub LM. Extensive degradation of recently synthesized collagen in gingiva of normal and streptozotocin-induced diabetic rats. J Dent Res 1984;63:23-27.
81. Takai N, Shinohara M, Yoshida Y, Ohura K, Mori M, Kakudo Y. Effect of streptozotocin diabetes on gingivitis in plaque-susceptible rats. J Dent Res 1986;65: 49-52.
82. Mahamed DA, Marleau A, Alnaeeli M, et al. G(-) anaerobes-reactive CD4+ T-cells trigger RANKL-mediated enhanced alveolar bone loss in diabetic NOD mice. Diabetes 2005;54:1477-1486.
83. Pontes Andersen CC, Flyvbjerg A, Buschard K, Holmstrup P. Periodontitis is associated with aggravation of prediabetes in Zucker fatty rats. J Periodontol 2007;78:559-565.
84. Andersen CCP, Buschard K, Flyvbjerg A, Stoltze K, Holmstrup P. Periodontitis deteriorates metabolic control in type 2 diabetic Goto-Kakizaki rats. J Periodontol 2006;77:350-356.
85. Al-Mashat HA, Kandru S, Liu R, Behl Y, Desta T, Graves DT. Diabetes enhances mRNA levels of proapoptotic genes and caspase activity, which contribute to impaired healing. Diabetes 2006;55:487-495.
86. He H, Liu R, Desta T, Leone C, Gerstenfeld LC, Graves DT. Diabetes causes decreased osteoclastogenesis, reduced bone formation, and enhanced apoptosis of osteoblastic cells in bacteria stimulated bone loss. Endocrinology 2004;145:447-452.
87. The Diabetes Control and Complications Trial Research Group. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 1995;44:968-983.
88. Li J, Schmidt AM. Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products. J Biol Chem 1997; 272:16498-16506.
89. Brett J, Schmidt AM, Yan SD, et al. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am J Pathol 1993;143:1699-1712.
90. Katz J, Bhattacharyya I, Farkhondeh-Kish F, Perez FM, Caudle RM, Heft MW. Expression of the receptor of advanced glycation end products in gingival tissues of type 2 diabetes patients with chronic periodontal disease: A study utilizing immunohistochemistry and RT-PCR. J Clin Periodontol 2005;32:40-44.
91. Lalla E, Lamster IB, Feit M, Huang L, Schmidt AM. A murine model of accelerated periodontal disease in diabetes. J Periodontal Res 1998;33:387-399.
92. Safkan-Seppala B, Ainamo J. Periodontal conditions in insulin-dependent diabetes mellitus. J Clin Periodontol 1992;19:24-29.
93. Sorsa T, Ingman T, Suomalainen K, et al. Cellular source and tetracycline-inhibition of gingival crevicular fluid collagenase of patients with labile diabetes mellitus. J Clin Periodontol 1992;19:146-149.
94. Seppala B, Sorsa T, Ainamo J. Morphometric analysis of cellular and vascular changes in gingival connective tissue in long-term insulin-dependent diabetes. J Periodontol 1997;68:1237-1245.
95. Wilson RM, Reeves WG. Neutrophil phagocytosis and killing in insulin-dependent diabetes. Clin Exp Immunol 1986;63:478-484.
96. Mowat A, Baum J. Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus. N Engl J Med 1971;284:621-627.
97. Kjersem H, Hilsted J, Madsbad S, Wandall JH, Johansen KS, Borregaard N. Polymorphonuclear leucocyte dysfunction during short term metabolic changes from normo- to hyperglycemia in type 1 (insulin dependent) diabetic patients. Infection 1988;16: 215-221.
98. Manouchehr-Pour M, Spagnuolo PJ, Rodman HM, Bissada NF. Impaired neutrophil chemotaxis in diabetic patients with severe periodontitis. J Dent Res 1981;60: 729-730.
99. Kim HS, Park JW, Yeo SI, Choi BJ, Suh JY. Effects of high glucose on cellular activity of periodontal ligament cells in vitro. Diabetes Res Clin Pract 2006;74: 41-47.
100. Glickman I, Smulow JB, Moreau J. Postsurgical periodontal healing in alloxan diabetes. J Periodontol 1967; 38:93-99.
101. Allen DA, Yaqoob MM, Harwood SM. Mechanisms of high glucose-induced apoptosis and its relationship to diabetic complications. J Nutr Biochem 2005;16: 705-713.
102. Doi K, Hasegawa K, Fujita M, et al. Clinical characteristics relevant to myocardial cell apoptosis: Analysis of pericardial fluid. Interact Cardiovasc Thorac Surg 2004;3:359-362.
103. Baumgartner-Parzer SM, Wagner L, Pettermann M, Grillari J, Gessl A, Waldhausl W. High-glucose-triggered apoptosis in cultured endothelial cells. Diabetes 1995;44:1323-1327.
104. Liu R, Desta T, He H, Graves DT. Diabetes alters the response to bacteria by enhancing fibroblast apoptosis. Endocrinology 2004;145:2997-3003.
105. Listgarten MA, Ricker FH Jr., Laster L, Shapiro J, Cohen DW. Vascular basement lamina thickness in the normal and inflamed gingiva of diabetics and non-diabetics. J Periodontol 1974;45:676-684
106. Frantzis TG, Reeve CM, Brown AL Jr. The ultrastructure of capillary basement membranes in the attached gingiva of diabetic and nondiabetic patients with periodontal disease. J Periodontol 1971;42: 406-411.
107. Murrah VA. Diabetes mellitus and associated oral manifestations: A review. J Oral Pathol 1985;14: 271-281.
108. Karachalias N, Babaei-Jadidi R, Ahmed N, Thornalley PJ. Accumulation of fructosyl-lysine and advanced glycation end products in the kidney, retina and peripheral nerve of streptozotocin-induced diabetic rats. Biochem Soc Trans 2003;31:1423-1425.
109. 2, IL-1 beta, and TNF-alpha responses in diabetics as modifiers of periodontal disease expression. Ann Periodontol 1998; 3:40-50.
110. Kolb H, Mandrup-Poulsen T. An immune origin of type 2 diabetes? Diabetologia 2005;48:1038-1050.
111. Engebretson SP, Hey-Hadavi J, Ehrhardt FJ, et al. Gingival crevicular fluid levels of interleukin-1beta and glycemic control in patients with chronic periodontitis and type 2 diabetes. J Periodontol 2004;75: 1203-1208.
112. Graves DT, Liu R, Alikhani M, Al-Mashat H, Trackman PC. Diabetes-enhanced inflammation and apoptosis - Impact on periodontal pathology. J Dent Res 2006; 85:15-21.
113. Hotamisligil GS, Amer P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995;95:2409-2415.
114. Fernandez-Real JM, Ricart W. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 2003;24:278-301.
115. Garcia-Welsh A, Schneiderman JS, Baly DL. Interleukin-1 stimulates glucose transport in rat adipose cells: Evidence for receptor discrimination between IL-1[beta] and IL-1. FEBS Lett 1990;269:421-424.
116. Zykova SN, Jenssen TG, Berdal M, Olsen R, Myklebust R, Seljelid R. Altered cytokine and nitric oxide secretion in vitro by macrophages from diabetic type II-like db/db mice. Diabetes 2000;49:1451-1458.
117. Oxford GE, Tayari L, Barfoot MD, Peck AB, Tanaka Y, Humphreys-Beher MG. Salivary EGF levels reduced in diabetic patients. J Diabetes Complications 2000;14:140-145.
118. Nagy A, Nagashima H, Cha S, et al. Reduced oral wound healing in the NOD mouse model for type 1 autoimmune diabetes and its reversal by epidermal growth factor supplementation. Diabetes 2001;50: 2100-2104.
119. Ficara AJ, Levin MP, Grower MF, Kramer GD. A comparison of the glucose and protein content of gingival fluid from diabetics and nondiabetics. J Periodontal Res 1975;10:171-175.
120. Thorstensson H, Dahlen G, Hugoson A. Some suspected periodontopathogens and serum antibody response in adult long-duration insulin-dependent diabetics. J Clin Periodontol 1995;22:449-458.
121. Tervonen T, Oliver RC. Long-term control of diabetes mellitus and periodontitis. J Clin Periodontol 1993; 20:431-435.
122. Sbordone L, Ramaglia L, Barone A, Ciaglia RN, Tenore A, Iacono VJ. Periodontal status and selected cultivable anaerobic microflora of insulin-dependent juvenile diabetics. J Periodontol 1995;66:452-461.
123. Sbordone L, Ramaglia L, Barone A, Ciaglia RN, Iacono VJ. Periodontal status and subgingival microbiota of insulin-dependent juvenile diabetics: A 3-year longitudinal study. J Periodontol 1998;69: 120-128.
124. Sastrowijoto SH, Hillemans P, van Steenbergen TJ, Abraham-Inpijn L, de Graaff J. Periodontal condition and microbiology of healthy and diseased periodontal pockets in type 1 diabetes mellitus patients. J Clin Periodontol 1989;16:316-322.
125. Zambon JJ, Reynolds H, Fisher JG, Shlossman M, Dunford R, Genco RJ. Microbiological and immunological studies of adult periodontitis in patients with noninsulin-dependent diabetes mellitus. J Periodontol 1988;59:23-31.
126. Mashimo PA, Yamamoto Y, Slots J, Park BH, Genco RJ. The periodontal microflora of juvenile diabetics. Culture, immunofluorescence, and serum antibody studies. J Periodontol 1983;54:420-430.
127. Mandell RL, Dirienzo J, Kent R, Joshipura K, Haber J. Microbiology of healthy and diseased periodontal sites in poorly controlled insulin dependent diabetics. J Periodontol 1992;63:274-279.
128. Ciantar M, Gilthorpe MS, Hurel SJ, Newman HN, Wilson M, Spratt DA. Capnocytophaga spp. in periodontitis patients manifesting diabetes mellitus. J Periodontol 2005;76:194-203.
129. Graves DT, Al-Mashat H, Liu R. Evidence that diabetes mellitus aggravates periodontal diseases and modifies the response to an oral pathogen in animal models. Compend Contin Educ Dent 2004;25:38-45.
130. Prando R, Cheli V, Melga P, Giusti R, Ciuchi E, Odetti P. Is type 2 diabetes a different disease in obese and nonobese patients? Diabetes Care 1998;21:1680-1685.
131. Rodrigues DC, Taba M, Novaes AB, Souza SLS, Grisi MFM. Effect of non-surgical periodontal therapy on glycemic control in patients with type 2 diabetes mellitus. J Periodontol 2003;74:1361-1367.
132. Promsudthi A, Pimapansri S, Deerochanawong C, Kanchanavasita W. The effect of periodontal therapy on uncontrolled type 2 diabetes mellitus in older subjects. Oral Dis 2005;11:293-298.
133. Miller LS, Manwell MA, Newbold D, et al. The relationship between reduction in periodontal inflammation and diabetes control: A report of 9 cases. J Periodontol 1992;63:843-848.
134. Iwamoto Y, Nishimura F, Nakagawa M, et al. The effect of antimicrobial periodontal treatment on circulating tumor necrosis factor-alpha and glycated hemoglobin level in patients with type 2 diabetes. J Periodontol 2001;72:774-778.
135. Grossi SG, Skrepcinski FB, DeCaro T, et al. Treatment of periodontal disease in diabetics reduces glycated hemoglobin. J Periodontol 1997;68:713-719.
136. Faria-Almeida R, Navarro A, Bascones A. Clinical and metabolic changes after conventional treatment of type 2 diabetic patients with chronic periodontitis. J Periodontol 2006;77:591-598.
137. Williams RC Jr., Mahan CJ. Periodontal disease and diabetes in young adults. JAMA 1960;172:776-778.
138. Collin HL, Uusitupa M, Niskanen L, et al. Periodontal findings in elderly patients with non-insulin dependent diabetes mellitus. J Periodontol 1998;69:962-966.
139. Taylor GW, Burt BA, Becker MP, et al. Severe periodontitis and risk for poor glycemic control in patients with non-insulin-dependent diabetes mellitus. J Periodontol 1996;67:1085-1093.
140. Thorstensson H, Kuylenstierna J, Hugoson A. Medical status and complications in relation to periodontal disease experience in insulin-dependent diabetics. J Clin Periodontol 1996;23:194-202.
141. Karjalainen KM, Knuuttila ML, von Dickhoff KJ. Association of the severity of periodontal disease with organ complications in type 1 diabetic patients. J Periodontol 1994;65:1067-1072.
142. Finestone AJ, Boorujy SR. Diabetes mellitus and periodontal disease. Diabetes 1967;16:336-340.
143. Kuroe A, Taniguchi A, Sekiguchi A, et al. Prevalence of periodontal bacterial infection in non-obese Japanese type 2 diabetic patients: Relationship with C-reactive protein and albuminuria. Horm Metab Res 2004;36:116-118.
144. Saremi A, Nelson RG, Tulloch-Reid M, et al. Periodontal disease and mortality in type 2 diabetes. Diabetes Care 2005;28:27-32.
145. Grossi SG, Genco RJ. Periodontal disease and diabetes mellitus: A two-way relationship. Ann Periodontol 1998;3:51-61.
146. Grimble RF. Inflammatory status and insulin resistance. Curr Opin Clin Nutr Metab Care 2002;5: 551-559.
147. Salvi GE, Collins JG, Yalda B, Arnold RR, Lang NP, Offenbacher S. Monocytic TNF alpha secretion patterns in IDDM patients with periodontal diseases. J Clin Periodontol 1997;24:8-16.
148. Cutler CW, Shinedling EA, Nunn M, et al. Association between periodontitis and hyperlipidemia: Cause or effect? J Periodontol 1999;70:1429-1434.
149. Takeda M, Ojima M, Yoshioka H, et al. Relationship of serum advanced glycation end products with deterioration of periodontitis in type 2 diabetes patients. J Periodontol 2006;77:15-20.
150. Sullivan KE, Cutilli J, Piliero LM, et al. Measurement of cytokine secretion, intracellular protein expression, and mRNA in resting and stimulated peripheral blood mononuclear cells. Clin Diagn Lab Immunol 2000;7:920-924.
151. Nichols TC, Fischer TH, Deliargyris EN, Baldwin AS. Role of nuclear factor-kappa B (NF-kappa B) in inflammation, periodontitis, and atherogenesis. Ann Periodontol 2001;6:20-29.